Given that our experiments with ectopically integrated CGIs suggested that aberrantly methylated CGIs were not strongly targeted by de novo DNMT activity, we next sought to determine which CGIs were targeted by DNMTs in colorectal cancer. The gene discussed is DNMT1; the disease is colorectal cancer.